Evaluation of Risk Markers Fluctuation During an Initial Therapy with Rosiglitazon in Patients Suffering from Metabolic Syndrome. (2009). Biomolecules and Biomedicine, 9(4), 320-328. https://doi.org/10.17305/bjbms.2009.2788